HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

polybutyl methacrylate (PBMA)

Also Known As:

PBMA; 2-Propenoic acid, 2-methyl-, butyl ester, homopolymer

Networked: 8 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Ai, Jie: 1 article (11/2021)
2.	Chen, Jiawen: 1 article (11/2021)
3.	Chen, Qinhui: 1 article (11/2021)
4.	Guo, Ying: 1 article (11/2021)
5.	Lin, Jianrong: 1 article (11/2021)
6.	Liu, Jinling: 1 article (11/2021)
7.	Avramoglou, Thierry: 1 article (01/2019)
8.	Boisson-Vidal, Catherine: 1 article (01/2019)
9.	Caligiuri, Giuseppina: 1 article (01/2019)
10.	Campagnolo, Valter: 1 article (01/2019)

Related Diseases

1.	Acute Kidney Injury (Acute Renal Failure) 01/01/2019 - "The G-PBMa introduction determined lower (P = 0.02) chest drain blood loss, lower (P = 0.001) postoperative acute kidney injury and shorter (P = 0.001) hospital stay. "
2.	Stroke (Strokes) 03/14/2018 - "Results were presented as net monetary benefit (NMB) and using Programme Budgeting and Marginal Analysis (PBMA) to assess the costs and benefits of a hypothetical typical region in England with approximately 4000 strokes a year. "
3.	Wounds and Injuries (Trauma) 12/01/2008 - "The poly(CMB-r-BMA) film significantly enhanced wound closure and complete healing of a full-thickness excisional wound compared with the effect of the poly(n-butyl methacrylate) (PBMA) and the poly(ethylene terephthalate) (PET) films. "
4.	Inflammation (Inflammations) 06/01/2014 - "After three months, the PLGA/ACP group still displayed lower inflammation score (1.33 +/- 0.33 vs. 2.27 +/- 0.55, P < 0.05) and higher endothelial scores (2.33 +/- 0.33 vs. 1.20 +/- 0.18, P < 0.05) as compared with the PEVA/PBMA group. " 06/01/2014 - "Comparing with both PEVA/PBMA and PLGA groups after one month, the results showed that stents coated with PLGA/ACP had significantly reduced restenosis (PLGA/ACP vs. PEVA/PBMA vs. PLGA: 21.24 +/- 2.59% vs. 27.54 +/- 1.19% vs. 32.12 +/- 3.93%, P < 0.05), reduced inflammation (1.25 +/- 0.35 vs. 1.77 +/- 0.38 vs. 2.30 +/- 0.21, P < 0.05) and increased speed of re-endothelialization (1.78 +/- 0.46 vs. 1.17 +/- 0.18 vs. 1.20 +/- 0.18, P < 0.05). "
5.	Hyperplasia 01/01/2019 - "Methods: Here, we investigated: (1) the effectiveness of polymer coating under physiological conditions and its ability to release Tacrolimus®, (2) the capacity of Dex-PBMA to inhibit Staphylococcus aureus adhesion, (3) the thrombin generation and the human platelet adhesion in static and dynamic conditions, (4) the biocompatibility properties in vitro on human endothelial colony forming cells ( ECFC) and on mesenchymal stem cells (MSC) and in vivo in rat models, and (5) we implanted Dex-PBMA and Dex-PBMATAC coated stents in neointimal hyperplasia restenosis rabbit model. "

Related Drugs and Biologics

1.	Thrombin
2.	Polymers
3.	poly(butyl methacrylate)
4.	ethylene
5.	terephthalic acid (terephthalate)

Related Therapies and Procedures

1.	Stents
2.	Length of Stay